Title: Lawrence Horowitz: Innovator in Synthetic Peptide Libraries Introduction Lawrence Horowitz is a notable inventor based in the United States, recognized for his contributions to the field of synthetic peptides and polypeptides. With a focus on innovative methods for creating diverse peptide libraries, his work has significant implications in biotechnology and pharmaceuticals. Latest Patents Although Lawrence Horowitz holds no patents, his latest inventions include the design and construction of diverse synthetic peptide and polypeptide libraries. This invention concerns methods of analytical database design for creating datasets using multiple relevant parameters as filters. Additionally, he has developed methods for generating sequence diversity through directed multisyntheses oligonucleotide synthesis. These methods enable the reduction of large complex annotated databases to simpler datasets of related sequences, based on relevant single or multiple key parameters that can be individually defined. Furthermore, he has worked on constructs and libraries comprising antibody surrogate light chain sequences, which include constructs comprising VpreB sequences partnered with other polypeptides, such as antibody heavy chain variable domain sequences. Career Highlights Lawrence Horowitz is currently associated with I2 Pharmaceuticals, Inc., where he continues to advance his research in synthetic peptides. His work is pivotal in the development of innovative solutions in the pharmaceutical industry. Collaborations He has collaborated with notable colleagues, including Ramesh R Bhatt and Arun K Kashyap, contributing to a dynamic research environment that fosters innovation. Conclusion Lawrence Horowitz's work in synthetic peptide libraries showcases his commitment to advancing biotechnology. His innovative approaches and collaborations highlight the importance of research in developing new therapeutic solutions.

Growing community of inventors

US

Lawrence Horowitz